Hawley rejects the idea that the timing of his mifepristone ban is about the midterms
Josh HawleyUnited States Senator for Missouri, responding to questions from Axios
Asked by Axios about Republican unease that his bill would raise abortion before the midterm elections, Hawley said the measure was not driven by the electoral calendar but by protecting women's health and the unborn. He added that opposition to abortion is "a foundational issue for the Republican Party" and that anti-abortion voters are the party's most dependable.
“This isn't about a political cycle, this is about protecting the health and safety of women, and also protecting the unborn.”
Reporting
Other statements by Josh Hawley in this case
- Josh Hawley supports Hawley's mifepristone banEarlier: Defended or excused
- Hawley unveils the "Declaration for Life" and asks candidates to commit to banning the abortion drugLater: Defended or excused
- Hawley urges FDA action on abortion-drug availabilityLater: Defended or excused
Where this statement fits
Should Congress ban the abortion pill, mifepristone, as Josh Hawley has proposed?
On March 11, 2026, Senator Josh Hawley introduced the Safeguarding Women from Chemical Abortion Act, which would withdraw the Food and Drug Administration's approval of mifepristone for pregnancy termination, make distributing and labeling the drug for that purpose violations of the Federal Food, Drug and Cosmetic Act, and let women who say chemical abortion harmed them sue its manufacturers. Mifepristone has been approved in the United States since 2000 and is used in a large majority of American abortions. Hawley argues a national ban is the only remedy because the drug can be mailed into states whose own laws restrict abortion. The bill drew seven Republican cosponsors but has not moved out of the Senate Health, Education, Labor and Pensions Committee. On September 16, 2026, Hawley unveiled a four-page "Declaration for Life" and began asking officeholders and candidates to sign it as a commitment to ban the drug. The dispute is over whether Congress should enact that ban.
Source and context
Reporting
About this source
The fullest available account of Senate Republican reluctance on the bill, with direct responses from Husted and Tillis, Hawley's reply to Axios, and Marjorie Dannenfelser's criticism of the Trump administration's handling of mifepristone litigation.
Archived copy (opens in a new tab)Before the quotation
Axios reported that Hawley's push was elevating an issue many Republicans hoped to avoid before the midterms.
After the quotation
The same report recorded that Senator John Cornyn had endorsed the bill while Senators Thom Tillis and Jon Husted each said they had not seen it.
How this statement is classified
The label describes this statement's response within the context above.
Why this label?
He defends that proposition against the objection that it is electorally reckless, restating its justification rather than qualifying it. The closest competing label is “Mixed or conditional”, since he is responding to a political objection rather than making a fresh policy argument. That loses because he concedes nothing and attaches no condition; the remark reaffirms the ban on the same grounds he gave when introducing it.
- Recorded on
- Published here
More from this case
Read the full caseGenBioPro declines to comment on Hawley's bill to ban mifepristone
GenBioPro
“At this time, the company prefers not to comment.”Read statement
Tony Perkins says the Republican Party has "lost its voice" on abortion and credits Hawley with filling the vacuum
“Unfortunately the Republican Party has lost its voice on the life issue and in that vacuum there are leaders that are stepping forward like Sen. Hawley calling upon the church, communities and the country to step up on behalf of the unborn.”Read statement
USCCB pro-life committee urges Congress to pass the mifepristone ban bill
U.S. Conference of Catholic Bishops
“In withdrawing FDA approval of mifepristone for abortion, prohibiting its being labeled for abortion, and ensuring a private right of action against manufacturers, the Safeguarding Women from Chemical Abortion Act, would likely save lives by curtailing the incidence of chemical abortion itself and all of its associated risks to the mothers as well. We are very grateful for your leadership in addressing this serious moral issue, and we urge your colleagues in both the House and Senate to support and pass this bill.”Read statement
Share or embed this statement
The embed keeps its attribution link to The Dispute Index. Credit the image to The Dispute Index and link to the statement page.
Cite this record
- Publisher
- The Dispute Index
- Title
- Hawley rejects the idea that the timing of his mifepristone ban is about the midterms
- First published
- Last updated
- Permalink
- https://disputeindex.com/events/1029-asked-by-axios-about-republican-unease-that-his
Last updated marks the most recent saved version of this published statement.
The Dispute Index. "Hawley rejects the idea that the timing of his mifepristone ban is about the midterms". First published: 2026-09-18. Last updated: 2026-09-25. https://disputeindex.com/events/1029-asked-by-axios-about-republican-unease-that-his